Role of LRP-1 in cancer cell migration in 3-dimensional collagen matrix

Cell Adh Migr. 2017 Jul 4;11(4):316-326. doi: 10.1080/19336918.2016.1215788. Epub 2016 Jul 27.

Abstract

The low-density lipoprotein receptor-related protein-1 (LRP-1) is a member of Low Density Lipoprotein Receptor (LDLR) family, which is ubiquitously expressed and which is described as a multifunctional endocytic receptor which mediates the clearance of various extracellular matrix molecules including serine proteinases, proteinase-inhibitor complexes, and matricellular proteins. Several studies showed that high LRP-1 expression promotes breast cancer cell invasiveness, and LRP-1 invalidation leads to cell motility abrogation in both tumor and non-tumor cells. Furthermore, our group has reported that LRP-1 silencing prevents the invasion of a follicular thyroid carcinoma despite increased pericellular proteolytic activities from MMP2 and uPA using a 2D-cell culture model. As the use of 3D culture systems is becoming more and more popular due to their promise as enhanced models of tissue physiology, the aim of the present work is to characterize for the first time how the 3D collagen type I matrix may impact the ability of LRP-1 to regulate the migratory properties of thyroid carcinoma using as a model FTC-133 cells. Our results show that inhibition of LRP-1 activity or expression leads to morphological changes affecting cell-matrix interactions, reorganizations of the actin-cytoskeleton especially by inhibiting FAK activation and increasing RhoA activity and MLC-2 phosphorylation, thus preventing cell migration. Taken together, our results suggest that LRP-1 silencing leads to a decrease of cell migratory capacity in a 3D configuration.

Keywords: 3D matrix; FTC-133 cells; LRP-1; collagen type I; migration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Movement* / drug effects
  • Cell Shape / drug effects
  • Collagen / pharmacology*
  • Enzyme Activation / drug effects
  • Extracellular Matrix / metabolism*
  • Focal Adhesion Protein-Tyrosine Kinases / metabolism
  • Gene Silencing
  • Humans
  • LDL-Receptor Related Protein-Associated Protein / pharmacology
  • Low Density Lipoprotein Receptor-Related Protein-1 / metabolism*
  • Myosin Light Chains / metabolism
  • Rats
  • Recombinant Proteins / pharmacology
  • Reproducibility of Results
  • Thyroid Neoplasms / metabolism*
  • Thyroid Neoplasms / pathology*

Substances

  • LDL-Receptor Related Protein-Associated Protein
  • Low Density Lipoprotein Receptor-Related Protein-1
  • Myosin Light Chains
  • Recombinant Proteins
  • Collagen
  • Focal Adhesion Protein-Tyrosine Kinases